<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Bekker | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/quietvinyl54/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/quietvinyl54/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bekker.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ccadf396cc75cb2d9718f991f3a066a9</guid>
				<title>Bekker posted an update: 05). Immunohistochemistry staining revealed that both AKT1 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42513/</link>
				<pubDate>Sun, 09 Feb 2025 09:47:51 -0800</pubDate>

									<content:encoded><![CDATA[<p>05). Immunohistochemistry staining revealed that both AKT1 and P38A were localized in the colonic mucosa and were significantly decreased in the aganglionic segment. CONCLUSION To our knowledge, we report for the first time the expression of RET regulatory network genes in the colons of patients with HSCR. The markedly decreased expression of AKT1&hellip;<span class="activity-read-more" id="activity-read-more-42513"><a href="http://www.nationalboardinstitute.com/activity/p/42513/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9ef8491c35e287241199d622a395d958</guid>
				<title>Bekker posted an update: The new reference, ARS-UCD1.2, successfully assembled [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40871/</link>
				<pubDate>Fri, 07 Feb 2025 09:44:00 -0800</pubDate>

									<content:encoded><![CDATA[<p>The new reference, ARS-UCD1.2, successfully assembled germline immune gene clusters and improved overall continuity (i.e., reduction of gaps and inversions) by over 250-fold. This reference properly places nearly all of the legacy genetic markers used for over a decade in the industry. In this review, we discuss the improvements made to the cattle&hellip;<span class="activity-read-more" id="activity-read-more-40871"><a href="http://www.nationalboardinstitute.com/activity/p/40871/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">41e0709185185c71e2be7f708267e141</guid>
				<title>Bekker posted an update: As COVID-19 pandemic continues to explode, cancer centers [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37260/</link>
				<pubDate>Mon, 03 Feb 2025 09:43:11 -0800</pubDate>

									<content:encoded><![CDATA[<p>As COVID-19 pandemic continues to explode, cancer centers worldwide are trying to adapt and are struggling with this constantly changing scenario. Intending to ensure patient safety and deliver quality care, we sought consensus on the preferred thoracic radiation regimen in a Canadian province with 4 new R&#8217;s of COVID era. BACKGROUND The COVID-19&hellip;<span class="activity-read-more" id="activity-read-more-37260"><a href="http://www.nationalboardinstitute.com/activity/p/37260/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1a6e7f913e8ec84338858532ef65795a</guid>
				<title>Bekker posted an update: AVAILABILITY The source code for the proposed method is [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35490/</link>
				<pubDate>Sat, 01 Feb 2025 09:44:26 -0800</pubDate>

									<content:encoded><![CDATA[<p>AVAILABILITY The source code for the proposed method is freely available at https//github.com/hyundoo/PRIME. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online. © The Author(s) (2020). Published by Oxford University Press. All rights reserved. For Permissions, please email <a href="mailto:journals.permissions@oup.com.Epidemic" rel="nofollow ugc">journals.permissions@oup.com.Epidemic</a>&hellip;<span class="activity-read-more" id="activity-read-more-35490"><a href="http://www.nationalboardinstitute.com/activity/p/35490/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b1fe1f5d6229fb9d7ecd0102f5b5abc9</guid>
				<title>Bekker posted an update: 2%; 16 primarily, 4 secondarily). Nine patients progressed [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33571/</link>
				<pubDate>Thu, 30 Jan 2025 09:49:28 -0800</pubDate>

									<content:encoded><![CDATA[<p>2%; 16 primarily, 4 secondarily). Nine patients progressed after the first FLE persistent FL flow with increase in aortic diameter and underwent repeat FLE with complete thrombosis (n=4) or open thoracoabdominal completion (n=5). 26 patients had indeterminate response FL thrombosis without change in maximum diameter; none have required&hellip;<span class="activity-read-more" id="activity-read-more-33571"><a href="http://www.nationalboardinstitute.com/activity/p/33571/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4f549788cfa6a9e517c6fd31fbd5854c</guid>
				<title>Bekker posted an update: in addition to lengthened sections. Case III models (2) and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30530/</link>
				<pubDate>Tue, 28 Jan 2025 15:19:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>in addition to lengthened sections. Case III models (2) and (3) showed lengthened sections (up to 5 and 23.4%, respectively) in addition to shortened sections. These effects get more pronounced with stiffer epimuscular connections. Assessments of forces exerted on the muscle by the epimuscular connections showed that such strain heterogeneities&hellip;<span class="activity-read-more" id="activity-read-more-30530"><a href="http://www.nationalboardinstitute.com/activity/p/30530/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">805e2d0e35856f8ade04d66f4a53da2d</guid>
				<title>Bekker became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30511/</link>
				<pubDate>Tue, 28 Jan 2025 15:17:22 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>